Merck KGaA has teamed up with Flagship Pioneering's Valo Health on an ambitious project to apply AI to the discovery of novel drug targets and therapeutics for Parkinson's disease. The partnership ...

Innovent Biologics has picked up approval in China for Pecondle, its anti-IL-23p19 antibody, as a treatment for ...

The DaRe2THINK platform – developed by the University of Birmingham and the MHRA's Clinical Practice Research Datalink (CPRD) ...

The federal government shutdown meant that the Securities & Exchange Commission (SEC), which oversees listing processes in ...

Radiopharmaceutical innovator AdvanCell has appointed Andrew Kay as Chair of the Board. Kay previously served as CEO of ...

The NHS’s Online Hospital ambition signals intent. But to make it real, the focus must move from building a digital replica ...

In a new pharmaphorum podcast, web editor Nicole Raleigh is joined by Piet van der Graaf, Senior VP at Certara – a company ...

A clinical trial of Vaderis Therapeutics' AKT inhibitor engasertib suggests it could be the first effective treatment for ...

UK researchers have developed a platform that can test whether commercial AI algorithms developed for NHS applications are ...

Direct-to-Patient (DTP) platforms represent a new frontier in patient support services. Properly executed, they help more ...

Donor plasma samples contain information that could lead to massive advances in disease prevention. pharmaphorum grabbed a ...

Rob Milnes (Ultrahuman) connected with pharmaphorum off the Frontiers Health stage to share some insights, following a ...